Descovy

 Descovy is a combination of emtricitabine and tenofovir alafenamide, used for the treatment and prevention of HIV-1 in certain individuals. It works by blocking reverse transcriptase, an enzyme HIV uses to replicate.

Benefits
• Effective once-daily HIV treatment
• Also approved for HIV prevention (PrEP)
• Fewer kidney and bone side effects compared to older options
• Small, easy-to-swallow tablet

Dosage
• Each tablet contains 200 mg emtricitabine and 25 mg tenofovir alafenamide
• Taken once daily with or without food
• Must be taken consistently for full benefit
• Do not skip doses

Warnings and Precautions
• Not recommended as PrEP in people assigned female at birth with vaginal sex exposure
• Monitor kidney and liver function regularly
• May cause lactic acidosis in rare cases
• Do not use with other HIV medications without direction

Usage Instructions
• Take once daily, same time each day
• Do not miss doses, even when feeling well
• Inform your provider if you stop and restart treatment
• Regular testing required during PrEP use

Storage Information
• Store below 30°C (86°F)
• Keep in original bottle with desiccant
• Avoid moisture and heat
• Keep out of children’s reach

Common Side Effects
• Headache
• Nausea
• Fatigue
• Diarrhea